| 產(chǎn)品名稱 |
pHuIL-1R-II 75 [HuII75] |
| 商品貨號(hào) |
B171826 |
| Designations |
pHuIL-1R-II 75 [HuII75] |
| GenBank Number |
X59769
|
| Species |
Homo sapiens, human |
| Depositors |
Immunex Corporation, CL Wight, Immunex Corporation |
| Applications |
contains sequence interleukin 1 receptor, type II interleukin 1 receptor, beta; type II receptor in another host, produces protein interleukin 1 receptor, type II interleukin 1 receptor, beta; type II receptor |
| Insert |
DNA: cDNA Insert lengths(kb): 1.399999976158142 Tissue: B lymphocyte CB23 cell line Gene product: interleukin 1 receptor, type II(interleukin 1 receptor, beta; type II receptor) [IL1R2] Target Gene: interleukin 1 receptor, type II |
| Insert Size (kb) |
1.400 |
| Media |
ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
|
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Shipping Information |
Distributed: freeze-dried |
| Comments |
Restriction digests of the clone give the following sizes (kb): EcoRI--4.8, 2.2, 1.7; HindIII--8.7; BamHI--4.9, 2.0, 1.5. |
| References |
McMahan CJ, et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10: 2821-2832, 1991. PubMed: 1833184
. Purified thermostable nucleic acid polymerases enzyme from Pyrodictium species. European Patent
Gearing DP. Receptor for oncostatin M and leukemia inhibitory factor. US Patent 5,262,522 dated Nov 16 1993
|
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
